Christian Ottensmeier und Dna - Info zur Person

(1 - 12 von 14

)

First Human Demonstration of Significant, Persistent Antibody...

www.finanznachrichten.de

Inovio Biomedical & University of Southampton Collaborative Clinical Study Establishes Important Humoral Immune Response of Prostate Cancer DNA Vaccine Using...

Leukemia: Positive Early Results For WT1 DNA Vaccine Clinical Trial...

www.science20.com

The early results of a trial to treat leukemia with a WT1 DNA vaccine looks promising, according to a presentation at the DNA Vaccines conference in...

Prostate Cancer DNA Vaccine Shows Significant Responsewww.icr.ac.uk › news-archive › prostate-cancer-dna...

www.icr.ac.uk

· Like on Facebook Tweet on Twitter Share on LinkedIn ... Dr Christian Ottensmeier of the University of Southampton, principal investigator on ...

Inovio Biomedical's DNA Delivery Technology Enhances Potency of ...www.technologynetworks.com › ... › News

www.technologynetworks.com

· ... delivered by electroporation in animals can also be seen in humans,” said Dr. Christian Ottensmeier, clinical investigator of the study.

Advances in Biology and Therapy of Multiple Myeloma: Volume 2:...

books.google.nl

Following phase I/II trials with DNA vaccines, the challenge now is to examine whether clinical benefit will result. For this, an extensive trial of a DNA vaccine to target WT1 in chronic myeloid leukaemia has been approved, with control arms, and is currently recruiting in our institution (lead: Prof. Christian Ottensmeier).

Abstract 9035: An adjuvant clinical trial of SCIB1, a DNA ...pure.northampton.ac.uk › abstract-...

pure.northampton.ac.uk

Poulam M Patel, Christian Ottensmeier, Clive Mulatero, Paul Lorigan, Ruth Plummer, Drew Hannaman, Michelle Cunnell, Rachael L Metheringham, Victoria A ...

Winning the battle against leukemia: Positive early results in...

www.sciencedaily.com

Early results of a trial to treat leukemia with a WT1 DNA vaccine, has shown robust vaccine-specific antibody responses in all vaccinated patients evaluated to...

Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution...

www.nature.com

Circulating tumour DNA profiling in early-stage non-small-cell lung cancer can be used to track single-nucleotide variants in plasma to predict lung cancer...